Treg-specific ST2 deletion enhances tumor-infiltrating CD8+ T cells in a mouse lung adenocarcinoma model [114], supporting the idea that IL-33/ST2 signaling-activated Treg cells exhibit pro-tumorigenic functions. The gene discussed is IL33; the disease is neoplasm.